Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash-Reference-Cited by-同舟云学术

Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash

Published:2017-04-12 Issue:21 Volume:8 Page:35193-35204
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hichert Vivien¹²,Scholl Catharina¹²,Steffens Michael¹²,Paul Tanusree³,Schumann Christian⁴⁵,Rüdiger Stefan⁴,Boeck Stefan⁶⁷,Heinemann Volker⁶⁷,Kächele Volker⁸,Seufferlein Thomas⁸,Stingl Julia¹²

Affiliation:

1. Research Division, Federal Institute for Drugs and Medical Devices, Bonn, Germany

2. Centre for Translational Medicine, University Bonn Medical Faculty, Bonn, Germany

3. Institute of Pharmacology of Natural Products and Clinical Pharmacology, University of Ulm, Ulm, Germany

4. Department of Internal Medicine II, University of Ulm, Ulm, Germany

5. Pneumology, Thoracic Oncology, Sleep and Respiratory Critical Care Medicine, Clinics Kempten-Oberallgäu, Kempten, Germany

6. Department of Internal Medicine III and Comprehensive Cancer Center, Ludwig-Maximilians-University of Munich, Munich, Germany

7. DKTK, German Cancer Consortium, German Cancer Research Center, (DKFZ), Heidelberg, Germany

8. Department of Internal Medicine I, University of Ulm, Ulm, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects;Anais Brasileiros de Dermatologia;2023-07

2. Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity?;Expert Opinion on Drug Safety;2021-03-05

3. Keratinocytes apoptosis contributes to crizotinib induced-erythroderma;Toxicology Letters;2020-02

4. An inventory of medicinal products causing skin rash: Clinical and regulatory lessons;Experimental and Therapeutic Medicine;2019-07-31

5. Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology;Drug Safety;2019-01-16